Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-10

Clinical Trial Update: A Multi-center 12-week Study of HMS5552 in T2DM [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for HMS5552 in type 2 diabetes completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HMS5552

Snippet

Sponsor: Hua Medicine Limited | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2020-03-10